<ѻýҕl>10 ѻýҕl With the Lowest Hourly Rateѻýҕl> Calculated by annual salary divided by number of hours worked Feb 23, 2022
<ѻýҕl>Dyspnea in Woman With RA Reveals a Diaphragmatic Lipomaѻýҕl> MRI can help differentiate these benign soft-tissue masses from more aggressive liposarcomas Feb 22, 2022
<ѻýҕl>Predicting Treatment Response in Inflammatory Muscle Disordersѻýҕl> Swedish registry study elicits factors associated with improvement Feb 16, 2022
<ѻýҕl>Acute Muscle Weakness and Skin Rash Following a Lupus Diagnosisѻýҕl> Clinicians consider many differentials Feb 14, 2022
<ѻýҕl>Two Years On, Tremfya Still Shines in Psoriatic Arthritisѻýҕl> Efficacy increases in long-term extension data Feb 10, 2022
<ѻýҕl>Mystery: Why Would Hand OA Be Less Severe in Black People?ѻýҕl> Data contrast with previous findings for hip and knee osteoarthritis Feb 04, 2022
<ѻýҕl>Trial Data Confirm Heightened Risks With JAK Inhibitorѻýҕl> May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
<ѻýҕl>Psoriasis Patients, Docs Want to Do More to Prevent Heart Problemsѻýҕl> Despite well-known cardiovascular risks, most patients currently undertreated Jan 19, 2022
<ѻýҕl>Don't Expect Much From COVID Vax in This Patient Groupѻýҕl> With rituximab on board, even third doses didn't induce meaningful antibody response Jan 13, 2022
<ѻýҕl>Muddled Picture for Antidepressant as Osteoarthritis Pain Relieverѻýҕl> Trial in primary care setting fails to confirm benefit seen in specialty clinics Jan 06, 2022
<ѻýҕl>Success for Upadacitinib in PsA, Despite Concernsѻýҕl> JAK inhibitor nabs new indication after FDA called for boxed warnings on the class Dec 28, 2021
<ѻýҕl>Hydroxychloroquine Linked to Less Heart Risk in RA, Lupusѻýҕl> Current use of the antimalarial especially was particularly associated with less thrombosis Dec 28, 2021
<ѻýҕl>Another Trial, Another PRP Flop in Osteoarthritisѻýҕl> Fails to outperform saline in randomized trial Nov 23, 2021
<ѻýҕl>Another Study Confirms Gout Benefit With SGLT2 Inhibitorsѻýҕl> Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
<ѻýҕl>Biologic Disappoints for Arthritis Achilles' Inflammationѻýҕl> But phase III trial did find some patient-oriented benefits Nov 11, 2021
<ѻýҕl>For Systemic JIA, Start Biologics Earlyѻýҕl> Observational study shows excellent efficacy in systemic pediatric arthritis Nov 10, 2021
<ѻýҕl>HAE Still Drawing Attention From Drugmakersѻýҕl> Two new products show midstage promise in hereditary angioedema Nov 10, 2021
<ѻýҕl>Secukinumab: An Up-and-Coming Option in Giant Cell Arteritis?ѻýҕl> Phase II trial found sustained remission with steroid-sparing effects Nov 10, 2021
<ѻýҕl>Voclosporin Benefits in Nephritis Persist at 30 Monthsѻýҕl> No new safety signals seen in long-term extension for lupus nephritis Nov 09, 2021
<ѻýҕl>Avacopan Helps Vasculitis Patients With Renal Impairment Wean Off Steroidsѻýҕl> Patients saw better eGFR recovery compared with prednisone Nov 08, 2021
<ѻýҕl>Vitamin D and Disease Prevention: Worth Another Look?ѻýҕl> Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
<ѻýҕl>Guselkumab Response Durable in Psoriatic Arthritisѻýҕl> Skin and joint improvements persisted through 2 years of follow-up Nov 08, 2021
<ѻýҕl>Early Biologics Better in Juvenile Idiopathic Arthritisѻýҕl> After 2 years, more patients on combo biologic/DMARD regimen had inactive disease Nov 08, 2021
<ѻýҕl>Brepocitinib Shows Promise in Phase II Trial for PsAѻýҕl> Oral tyrosine kinase 2/JAK-1 inhibitor improved both joint and skin manifestations Nov 07, 2021
<ѻýҕl>Could This Biologic Drug Work in Patients Lacking Its Target?ѻýҕl> Bizarre finding with omalizumab Nov 07, 2021
<ѻýҕl>Targeting IL-23 Succeeds in Psoriatic Arthritisѻýҕl> Patients had active, longstanding disease and inadequate responses to other agents Nov 07, 2021
<ѻýҕl>Can Abatacept Reverse Early Rheumatoid Arthritis?ѻýҕl> At-risk patients showed improvements in inflammation -- and also delays in disease onset Nov 06, 2021
<ѻýҕl>Mixed Results With Anti-Interleukin Biologics in Asthmaѻýҕl> One shows promise; another fails miserably (and mysteriously) Oct 27, 2021
<ѻýҕl>No Love for PRP in Ankle Osteoarthritis Trialѻýҕl> Dutch researchers throw cold water on popular therapy Oct 26, 2021
<ѻýҕl>Following Rituximab With Second Biologic Helpful in Lupusѻýҕl> Trial may provide answer for patients who don't respond to B-cell depletion Oct 25, 2021
<ѻýҕl>How Should Patients With Autoimmune Diseases Approach COVID Vaccination?ѻýҕl> Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<ѻýҕl>First Interchangeable Humira Biosimilar Approvedѻýҕl> Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
<ѻýҕl>FDA Gives Thumbs Up to ANCA-Associated Vasculitis Drugѻýҕl> Approval granted to avacopan despite advisory committee concerns Oct 08, 2021
<ѻýҕl>Is This the Future of Corticosteroids?ѻýҕl> Novel agent, aimed at doing away with adverse metabolic effects, proves mettle in DMD Oct 05, 2021
<ѻýҕl>Olfactory Loss Common in Sjogren's Syndromeѻýҕl> Objective impairments in olfaction correlated with disease activity and symptoms Sep 29, 2021
<ѻýҕl>In RA, Little Risk for Recurrent Cancer With Biologic Treatmentѻýҕl> Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<ѻýҕl>Statins Not Linked With Rheumatoid Arthritis, Large Study Findsѻýҕl> Risks attenuated after adjustment for lipid levels Sep 22, 2021
<ѻýҕl>IBD and Pediatric Arthritis: Exploring the Linkѻýҕl> Risk factors include enthesitis, family history, and etanercept use Sep 15, 2021
<ѻýҕl>Pneumocystis Often Lethal in Dermatomyositisѻýҕl> Incidence of pneumonia high in MDA5-antibody-positive patients Sep 10, 2021